For the three genes (SMAD2, DNMT1, and KLF4) mentioned above, their role in tumor progression and necroptosis is opposite, suggesting necroptosis may act as the “insurance” that prevent tumor metastasis and invasion. The gene discussed is KLF4; the disease is neoplasm.